Explore how AI and biomarkers are revolutionizing cancer risk assessment, moving from population statistics to personalized predictions for early detection and prevention.
Exploring the biological correlates of frailty in solid tumors and their implications for brain tumor patients, including biomarkers, research methods, and clinical applications.
Discover how monocytes, common white blood cells, are emerging as powerful predictors of immunotherapy outcomes in cancer treatment.
Discover how pharmacodynamic markers are revolutionizing cancer treatment by predicting Perifosine effectiveness through protein signatures and biological clues.
Discover how uPA/PAI-1 and HER2 biomarkers provide complementary information for personalized breast cancer treatment decisions in node-negative patients.
Explore how molecular biomarkers are transforming gastric cancer detection and treatment through cutting-edge research and innovative technologies.
Exploring how trace elements in our bodies may hold crucial clues for early breast cancer diagnosis through unique elemental fingerprints.
Discover how extracellular vesicles are transforming the diagnosis and treatment of primary aldosteronism, a common cause of high blood pressure.
Explore how proteomics is transforming medicine through early disease detection, test verification, and personalized therapy monitoring.
Explore how translational research is revolutionizing colorectal cancer treatment through biomarker discovery, proteomics, and personalized medicine approaches.